Cargando…

Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection

AIM: The purpose of this study was to analyze the sequence of azurin gene in relation to its expression in Pseudomanas aeruginosa strains isolated from different clinical specimens of burn patients. Moreover, in silico sequence analysis of azurin gene using globally reported sequences was intended....

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi Barzelighi, Hajar, Bakhshi, Bita, Daraei, Bahram, Fazeli, Hossein, Nasr Esfahani, Bahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367926/
https://www.ncbi.nlm.nih.gov/pubmed/32765002
http://dx.doi.org/10.2147/IDR.S248043
_version_ 1783560513944289280
author Mohammadi Barzelighi, Hajar
Bakhshi, Bita
Daraei, Bahram
Fazeli, Hossein
Nasr Esfahani, Bahram
author_facet Mohammadi Barzelighi, Hajar
Bakhshi, Bita
Daraei, Bahram
Fazeli, Hossein
Nasr Esfahani, Bahram
author_sort Mohammadi Barzelighi, Hajar
collection PubMed
description AIM: The purpose of this study was to analyze the sequence of azurin gene in relation to its expression in Pseudomanas aeruginosa strains isolated from different clinical specimens of burn patients. Moreover, in silico sequence analysis of azurin gene using globally reported sequences was intended. MATERIALS AND METHODS: Fifty-nine multidrug-resistant P. aeruginosa isolates were selected from different clinical specimens of patients suffering from burn wound infections in two university hospitals and subjected to antibacterial susceptibility testing. The frequency and genetic diversity of the azurin gene was determined by polymerase chain reaction (PCR) and Sanger sequencing. The azurin gene sequences were compared with the sequence data from other countries. The expression level of azurin gene in P. aeruginosa isolates with different azurin sequences from different clinical specimens was evaluated by real-time PCR. RESULTS AND CONCLUSION: About 98%–100% of the isolates were resistant to gentamicin, tobramycin, cefoxitin, ciprofloxacin, amikacin, and imipenem, while 100% and 23.9% of the isolates were susceptible to colistin and ceftazidime, respectively. Only eight point mutations were detected with amino acid substitutions in only two positions (81 and 102). In global analysis, 93% of strains showed missense mutation at positions 81 (alanine to threonine). The majority (81%) of Iranian strains were allocated to two major clusters distinct from the rest of world, which may suggest that strains from Iran have made a distinct genetic stockpile through point mutations which has established them separate from the other counties. However, 19% were distributed in different clusters together with the strains from different countries of North and South America, Europe, South and East Asia. The expression level of the azurin gene was statistically higher in the isolates collected from the blood of burns patients with systemic infection compared to the isolates collected from other specimens (wound, catheter and tissue), which shows a positive correlation between azurin gene expression and increased pathogenicity and capability for dissemination. This study may open new insight about azurin genetic variation and significance in P. aeruginosa pathogenesis.
format Online
Article
Text
id pubmed-7367926
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73679262020-08-05 Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection Mohammadi Barzelighi, Hajar Bakhshi, Bita Daraei, Bahram Fazeli, Hossein Nasr Esfahani, Bahram Infect Drug Resist Original Research AIM: The purpose of this study was to analyze the sequence of azurin gene in relation to its expression in Pseudomanas aeruginosa strains isolated from different clinical specimens of burn patients. Moreover, in silico sequence analysis of azurin gene using globally reported sequences was intended. MATERIALS AND METHODS: Fifty-nine multidrug-resistant P. aeruginosa isolates were selected from different clinical specimens of patients suffering from burn wound infections in two university hospitals and subjected to antibacterial susceptibility testing. The frequency and genetic diversity of the azurin gene was determined by polymerase chain reaction (PCR) and Sanger sequencing. The azurin gene sequences were compared with the sequence data from other countries. The expression level of azurin gene in P. aeruginosa isolates with different azurin sequences from different clinical specimens was evaluated by real-time PCR. RESULTS AND CONCLUSION: About 98%–100% of the isolates were resistant to gentamicin, tobramycin, cefoxitin, ciprofloxacin, amikacin, and imipenem, while 100% and 23.9% of the isolates were susceptible to colistin and ceftazidime, respectively. Only eight point mutations were detected with amino acid substitutions in only two positions (81 and 102). In global analysis, 93% of strains showed missense mutation at positions 81 (alanine to threonine). The majority (81%) of Iranian strains were allocated to two major clusters distinct from the rest of world, which may suggest that strains from Iran have made a distinct genetic stockpile through point mutations which has established them separate from the other counties. However, 19% were distributed in different clusters together with the strains from different countries of North and South America, Europe, South and East Asia. The expression level of the azurin gene was statistically higher in the isolates collected from the blood of burns patients with systemic infection compared to the isolates collected from other specimens (wound, catheter and tissue), which shows a positive correlation between azurin gene expression and increased pathogenicity and capability for dissemination. This study may open new insight about azurin genetic variation and significance in P. aeruginosa pathogenesis. Dove 2020-07-13 /pmc/articles/PMC7367926/ /pubmed/32765002 http://dx.doi.org/10.2147/IDR.S248043 Text en © 2020 Mohammadi Barzelighi et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mohammadi Barzelighi, Hajar
Bakhshi, Bita
Daraei, Bahram
Fazeli, Hossein
Nasr Esfahani, Bahram
Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection
title Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection
title_full Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection
title_fullStr Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection
title_full_unstemmed Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection
title_short Global Sequence Analysis and Expression of Azurin Gene in Different Clinical Specimens of Burn Patients with Pseudomonas aeruginosa Infection
title_sort global sequence analysis and expression of azurin gene in different clinical specimens of burn patients with pseudomonas aeruginosa infection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367926/
https://www.ncbi.nlm.nih.gov/pubmed/32765002
http://dx.doi.org/10.2147/IDR.S248043
work_keys_str_mv AT mohammadibarzelighihajar globalsequenceanalysisandexpressionofazuringeneindifferentclinicalspecimensofburnpatientswithpseudomonasaeruginosainfection
AT bakhshibita globalsequenceanalysisandexpressionofazuringeneindifferentclinicalspecimensofburnpatientswithpseudomonasaeruginosainfection
AT daraeibahram globalsequenceanalysisandexpressionofazuringeneindifferentclinicalspecimensofburnpatientswithpseudomonasaeruginosainfection
AT fazelihossein globalsequenceanalysisandexpressionofazuringeneindifferentclinicalspecimensofburnpatientswithpseudomonasaeruginosainfection
AT nasresfahanibahram globalsequenceanalysisandexpressionofazuringeneindifferentclinicalspecimensofburnpatientswithpseudomonasaeruginosainfection